4.4 Article

Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma

期刊

CLINICAL ENDOCRINOLOGY
卷 71, 期 4, 页码 581-586

出版社

WILEY-BLACKWELL
DOI: 10.1111/j.1365-2265.2009.03537.x

关键词

-

资金

  1. Asan Institute for Life Science, Seoul, Korea [2006-169]

向作者/读者索取更多资源

P>Objective The effect of coexistent chronic lymphocytic thyroiditis (CLT) on prognosis in papillary thyroid carcinoma (PTC) patients remains controversial. We evaluated the influence of coexistent CLT on prognostic outcome and the association of coexistent CLT with clinicopathological parameters. Design A retrospective study with a median follow-up of 70 months. Patients and measurements Patients with PTC who underwent total thyroidectomy followed by I-131 remnant ablation between 1995 and 2003 at Asan Medical Center, Seoul, Korea were enrolled. CLT was diagnosed histopathologically. Results Among 1441 patients, 214 (14 center dot 9%) had coexistent CLT. A greater female preponderance was noted in the patients with CLT compared with those without CLT (P < 0 center dot 01). Mean tumour size in the patients with CLT was smaller than that in patients without CLT (2 center dot 0 +/- 1 center dot 2 vs. 2 center dot 2 +/- 1 center dot 4 cm; P = 0 center dot 02). One hundred and fifty-one (12 center dot 3%) patients without CLT had recurrence, whereas 14 (7 center dot 1%) patients with CLT had recurrence during the follow-up period (P = 0 center dot 016). In patients with cervical lymph node metastases, those with coexistent CLT showed a significantly lower recurrence rate than those without CLT (P = 0 center dot 012). However, this association was lost on multivariate analysis adjusting for other clinicopathological predictors for recurrence. Conclusions In this study, CLT was commonly associated with PTC and was associated with smaller size of the primary tumour at presentation. CLT was also associated with a reduced risk of recurrence during follow-up, although this was not significant after adjustment for other prognostic factors.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据